Market report
Dermatological drug tenders in Czechia — market report, May 2025
Dermatological drug tenders in Czechia in May 2025: 6,887 tenders published (-14% month on month, +2% year on year), estimated at €36,694,455 in total, and 6,901 contracts awarded (-14% month on month, +2% year on year), worth €7,467,367 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (1,745), Fakultní nemocnice Bulovka (1,524) and Krajská zdravotní, a.s. (783); most contracts won: ViaPharma s.r.o. (239), ROCHE s.r.o. (218) and Janssen-Cilag s.r.o. (154). On average 2.0 bids per contract; 50% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 6,887
- Contracts awarded
- 6,901
- Contract value awarded
- €7,467,367
- Bids per contract
- 2.0
The highlighted bar is May 2025. Hover a bar for its figure; the table below has every value.
| Figure | May 2025 | April 2025 | Change | May 2024 | Change |
|---|---|---|---|---|---|
| Tenders published | 6,887 | 8,045 | -14% | 6,773 | +2% |
| Estimated value | €36,694,455 | €6,934,584 | +429% | €336,764 | +10,796% |
| Buyers | 25 | 31 | -19% | 32 | -22% |
| Contracts awarded | 6,901 | 8,051 | -14% | 6,771 | +2% |
| Contract value (awarded) | €7,467,367 | €5,714,987 | +31% | — | — |
| Winners | 247 | 264 | -6% | 289 | -15% |
| Bids per contract | 2.0 | 1.1 | — | — | — |
| Single-bid contracts | 50% | 90% | — | — | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 239 |
| 2 | ROCHE s.r.o. | 218 |
| 3 | Janssen-Cilag s.r.o. | 154 |
| 4 | Amgen s.r.o. | 109 |
| 5 | Gilead Sciences s.r.o. | 105 |
| 6 | Avenier a.s. | 101 |
| 7 | AbbVie s.r.o. | 99 |
| 8 | Takeda Pharmaceuticals Czech Republic s.r.o. | 99 |
| 9 | BAYER s.r.o. | 96 |
| 10 | Merck Sharp & Dohme s.r.o. | 82 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in May 2025?
- 6,887 (by 25 buyers); for comparison, April 2025: 8,045, May 2024: 6,773.
- Who won the most dermatological drug tenders in Czechia in May 2025?
- By number of contracts: ViaPharma s.r.o. (239), ROCHE s.r.o. (218), Janssen-Cilag s.r.o. (154), Amgen s.r.o. (109) and Gilead Sciences s.r.o. (105); 247 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in May 2025?
- Krajská nemocnice T. Bati, a. s. (1,745), Fakultní nemocnice Bulovka (1,524), Krajská zdravotní, a.s. (783), Fakultní nemocnice Brno (377) and Nemocnice České Budějovice, a.s. (308).
- How competitive were dermatological drug tenders in Czechia in May 2025?
- On average 2.0 bids per contract (28 contracts with a known number of bids); 50% of contracts had a single bid.
- What were the contracts worth in May 2025?
- €7,467,367 (awarded value, 6,901 contracts); median about €120,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.